Human Pathophysiology and Translational Medicine Graduate Program

Galveston, TX, United States

Human Pathophysiology and Translational Medicine Graduate Program

Galveston, TX, United States

Time filter

Source Type

Gunawardana M.,Oak Crest Institute of Science | Mullen M.,Oak Crest Institute of Science | Moss J.A.,Oak Crest Institute of Science | Pyles R.B.,UTMB | And 8 more authors.
PLoS ONE | Year: 2013

Background:Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap.Methodology/Principal Findings:Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43%) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83%) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types.Conclusions/Significance:Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over- or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP. © 2013 Gunawardana et al.

Loading Human Pathophysiology and Translational Medicine Graduate Program collaborators
Loading Human Pathophysiology and Translational Medicine Graduate Program collaborators